STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Medivir AB (STO:MVIRB) announces that the board of directors now has set the final terms for Medivir’s voluntary redemption programme. Every seventh share will be redeemable for a cash consideration of SEK 140 per share. The shareholders will receive one redemption right for each share held in Medivir. Seven redemption rights entitle to redemption of one share held. In total, a maximum amount of SEK 625,200,380 may be paid as proceeds for the redeemed shares.
Help employers find you! Check out all the jobs and post your resume.
